387PPreliminary results from subsets of patients (pts) with advanced gastric cancer (GC) and esophageal carcinoma (EC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)
Desai, J., Millward, M., Chao, Y., Gan, H., Voskoboynik, M., Markman, B., Townsend, A., Atkinson, V., Zhu, A., Song, J., Qi, Q., Kang, A., Deva, S.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx367.021
Date:
September, 2017
File:
PDF, 47 KB
english, 2017